SH3BGRL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.138220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.986500E-02
Normal-vs-Stage2
1.388000E-02
Normal-vs-Stage3
3.853900E-02
Normal-vs-Stage4
2.447400E-01
Stage1-vs-Stage2
8.041600E-01
Stage1-vs-Stage3
7.407200E-01
Stage1-vs-Stage4
2.154000E-01
Stage2-vs-Stage3
5.737400E-01
Stage2-vs-Stage4
2.235200E-01
Stage3-vs-Stage4
1.805630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.576600E-03
Normal-vs-AfricanAmerican
2.561600E-01
Normal-vs-Asian
2.963900E-02
Caucasian-vs-AfricanAmerican
3.861000E-01
Caucasian-vs-Asian
2.682400E-01
AfricanAmerican-vs-Asian
3.202800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.402900E-03
Normal-vs-Female
1.865740E-02
Male-vs-Female
1.420970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.054000E-02
Normal-vs-Age(41-60Yrs)
2.777700E-02
Normal-vs-Age(61-80Yrs)
1.253880E-02
Normal-vs-Age(81-100Yrs)
1.759230E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.153600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.129400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.896400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.908500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.225450E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.538800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.663300E-03
Normal-vs-Daily Drinker
1.559510E-04
Normal-vs-Weekly Drinker
1.160340E-02
Normal-vs-Occasional Drinker
2.978000E-02
Normal-vs-Social Drinker
1.452210E-01
Non Drinker-vs-Daily Drinker
1.919200E-01
Non Drinker-vs-Weekly Drinker
7.832600E-01
Non Drinker-vs-Occasional Drinker
2.290600E-01
Non Drinker-vs-Social Drinker
1.601410E-01
Daily Drinker-vs-Weekly Drinker
1.595210E-01
Daily Drinker-vs-Occasional Drinker
1.914040E-02
Daily Drinker-vs-Social Drinker
4.766100E-02
Weekly Drinker-vs-Occasional Drinker
4.477200E-01
Weekly Drinker-vs-Social Drinker
3.527200E-01
Occasional Drinker-vs-Social Drinker
7.170200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.614020E-01
Normal-vs-Grade 2
3.224000E-02
Normal-vs-Grade 3
7.127800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.163190E-01
Grade 1-vs-Grade 3
6.702200E-01
Grade 1-vs-Grade 4
1.614020E-01
Grade 2-vs-Grade 3
1.818370E-01
Grade 2-vs-Grade 4
3.224000E-02
Grade 3-vs-Grade 4
7.127800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.358410E-02
Normal-vs-NonDiabetic
7.197300E-03
Diabetic-vs-NonDiabetic
7.380800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.092200E-02
Normal-vs-NoPancreatitis
9.264600E-03
Pancreatitis-vs-NoPancreatitis
3.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.664260E-02
Normal-vs-N1
1.190050E-02
N0-vs-N1
5.122000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.780200E-03
Normal-vs-TP53-NonMutant
1.920230E-02
TP53-Mutant-vs-TP53-NonMutant
1.933560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
